European stocks mixed; Shell shines as quarterly earnings continue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Apple (AAPL) PT Raised to $230 at BofA Securities, 'many positive catalysts ahead'
May 3, 2024 9:32 AM EDTBofA Securities analyst Wamsi Mohan raised the price target on Apple (NASDAQ: AAPL) to $230.00 (from $225.00) while maintaining a Buy rating.
The analyst comments "The thesis for our upgrade to Buy earlier this year (see our note) is playing out with: (1) strong multi-year... More
Sotera Health (SHC) PT Lowered to $17 at RBC Capital
May 3, 2024 6:48 AM EDTRBC Capital analyst Sean Dodge lowered the price target on Sotera Health (NASDAQ: SHC) to $17.00 (from $20.00) while maintaining a Outperform rating.
The analyst comments "1Q24 results were mixed with revenue 1.5% above consensus and EBITDA 3.8% below on higher-than-expected COGS and SG&A. Along... More
Evercore ISI on Apple (AAPL): 'Making Apple Great Again. Maintain TOP PICK'
May 3, 2024 6:20 AM EDTEvercore ISI analyst Amit Daryanani reiterated an Outperform rating and $220.00 price target on Apple (NASDAQ: AAPL).
The analyst comments "AAPL reported better than expected set of numbers and crucially their commentary was much better than buyside fears. Stock should work higher from here as compares get easier, catalysts add up and AAPL executes on AI in a more capital efficient manner vs. other tech companies. March-qtr print came in at $90.8B/1.53 vs. street at $90.4B/1.51 as... More
Goldman Sachs Comments on Apple (AAPL)
May 3, 2024 6:04 AM EDTGoldman Sachs analyst Michael Ng reiterated a Buy rating and $226.00 price target on Apple (NASDAQ: AAPL).
The analyst comments "AAPL's F2Q24 EPS of $1.53 and revenue of $90.8 bn was in-line with our expectations, but beat consensus, largely on Services gross profit and other income. We gain confidence in our Buy rating with AAPL... More
BofA Securities Comments on Novo Nordisk (NVO)
May 3, 2024 5:55 AM EDTBofA Securities analyst Sachin Jain reiterated a Buy rating and $147.00 price target on Novo Nordisk (NYSE: NVO)
The analyst comments "Key takes from 1Q results: 1) 1Q24 adjusted EPS DKK5.68 +29%, 8% ahead of consensus, on 2% sales beat and operating margin 300bps ahead, mainly on S&D, offset by lower OOI (-DKK568m vs +DKK33m,... More
Apple (AAPL) PT Raised to $196 at Rosenblatt
May 3, 2024 5:46 AM EDTRosenblatt analyst Barton Crockett raised the price target on Apple (NASDAQ: AAPL) to $196.00 (from $189.00) while maintaining a Neutral rating.
The analyst comments "June Quarter Fears Beaten Back -- Apple also brushed aside Street concerns that the June quarter was pacing for a... More
Citi on Apple (AAPL) Earnings
May 3, 2024 5:32 AM EDTCiti analyst Atif Malik reiterated a Buy rating and $210.00 price target on Apple (NASDAQ: AAPL)
The analyst comments "AAPL stock was +6% after hours on a relief rally as modest 2c Mar-Q beat and LSD Jun-Q growth or $83B+ revenue. iPhone sales were... More
Tech analyst explains why he is long Apple stock into earnings
May 2, 2024 12:23 PM EDTA Lynx Equity Strategies analyst is long into Apple's (NASDAQ: AAPL) earnings release after the close today, stating he believes the iPhone maker is "the next idea to be discovered."
In a recent note, the analyst addresses concerns surrounding iPhone sales, attributing recent weakness to temporary production disruptions rather than systemic issues. They project a 3% increase in... More
Vestas shares fall after posting earnings loss, revenue decline
May 2, 2024 6:57 AM EDTVestas (OTC: VWDRY) shares fell Thursday after the company reported a first-quarter adjusted EBIT loss and lower revenue year-on-year.
Vestas's first quarter adjusted EBIT came in at -EUR68 million. Analysts had forecasted an adjusted EBIT profit for the company. Revenue for the quarter came in at EUR2.68 billion, 5.2% below the EUR2.83 billion reported in Q1 2023 and missing analyst consensus... More
Novo Nordisk (NVO) sales jump on strong demand for obesity drug
May 2, 2024 6:23 AM EDTNovo Nordisk (NYSE: NVO) reported a robust first quarter with a 24% increase in sales at constant exchange rates (CER), reaching DKK 65.35 billion. The company's operating profit also saw a significant rise, jumping by 30% at CER to DKK 31.8 billion. Despite these strong results, shares of the pharmaceutical giant fell by 2.83%.
The first quarter's performance was marked by a notable 34% sales increase in North America Operations, with a 35% increase at CER. This growth was largely attributed to adjustments in gross-to-net sales from previous years. International Operations also saw an 11% rise at CER. Within the... More
